• 6979 Citations
  • 43 h-Index
1988 …2019
If you made any changes in Pure these will be visible here soon.

Research Output 1988 2019

Filter
Editorial
Editorial

Can metronomic chemotherapy be an alternative to sorafenib in advanced hepatocellular carcinoma?

Kim, D. Y., 2017 Jun 1, In : Clinical and Molecular Hepatology. 23, 2, p. 123-124 2 p.

Research output: Contribution to journalEditorial

Open Access
Phenylurea Compounds
Antineoplastic Combined Chemotherapy Protocols
Intra Arterial Infusions
Liver Neoplasms
Hepatocellular Carcinoma
Coinfection
Hepacivirus
Antiviral Agents
Clinical Trials
HIV
1 Citation (Scopus)

Estimation of direct medical costs related to chronic hepatitis C: A rationale for early antiviral therapy

Kim, D. Y., 2017 Nov, In : Gut and liver. 11, 6, p. 745-746 2 p.

Research output: Contribution to journalEditorial

Ribavirin
Chronic Hepatitis C
Secondary Prevention
Combination Drug Therapy
Antiviral Agents

Hepatitis C viral kinetics as a determinant of stopping pegylated interferon and ribavirin in genotype 1 infection

Kim, D. Y., 2014 Jul, In : Gut and liver. 8, 4, p. 335-336 2 p.

Research output: Contribution to journalEditorial

Ribavirin
Chronic Hepatitis C
Hepatitis C
Recombinant Proteins
Interferon-alpha
Hepatocellular Carcinoma
sorafenib
1 Citation (Scopus)

Staging for hepatocellular carcinoma in light of tumor heterogeneity: Time to change or update?

Kim, D. Y. & Han, K. H., 2018 Jun, In : Hepatology. 67, 6, p. 2076-2078 3 p.

Research output: Contribution to journalEditorial

Hepatocellular Carcinoma
Neoplasms